The Metabolomics group develops and applies advanced molecular analysis technologies and workflows in (pre-) clinical research with a particular focus on patho-physiological mechanisms and drug development. The Metabolomics group is dedicated to translational research and collaborates with many partners from diverse scientific fields around the globe.